scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(95)92280-6 |
P698 | PubMed publication ID | 7658819 |
P50 | author | Tom Schröder | Q107267790 |
P2093 | author name string | L Kivisaari | |
V Valtonen | |||
M Taavitsainen | |||
P Puolakkainen | |||
E Kivilaakso | |||
R Haapiainen | |||
E Kemppainen | |||
V Sainio | |||
P2860 | cites work | Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices | Q34558106 |
Acute pancreatitis: the role of early surgery | Q36889690 | ||
Surgical strategies in the treatment of pancreatic necrosis and infection | Q37692087 | ||
Antibiotics in acute pancreatitis. Current status and future directions | Q38720616 | ||
Prognostic factors in sterile pancreatic necrosis | Q44024411 | ||
Pancreatic resection versus peritoneal lavation for acute fulminant pancreatitis. A randomized prospective study | Q44831912 | ||
Pancreatic abscess and infected pancreatic necrosis. Different local septic complications in acute pancreatitis | Q45275954 | ||
Early detection of acute fulminant pancreatitis by contrast-enhanced computed tomography. | Q64998215 | ||
A prospective study to determine the efficacy of antibiotics in acute pancreatitis | Q67492869 | ||
Early surgical débridement of symptomatic pancreatic necrosis is beneficial irrespective of infection | Q67736441 | ||
Pancreatic resection versus peritoneal lavage in acute necrotizing pancreatitis. A prospective randomized trial | Q67758145 | ||
Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. A prospective study of 202 patients | Q68272333 | ||
Bacterial contamination of pancreatic necrosis. A prospective clinical study | Q68883830 | ||
Early diagnosis of pancreatic infection by computed tomography-guided aspiration | Q69445425 | ||
Surgical management of necrotizing pancreatitis | Q69505039 | ||
Septicemia. Etiology, epidemiology, clinical aspects and prognosis in 446 patients | Q70307402 | ||
A new method for the diagnosis of acute hemorrhagic-necrotizing pancreatitis using contrast-enhanced CT | Q71353948 | ||
P433 | issue | 8976 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 663-667 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Early antibiotic treatment in acute necrotising pancreatitis | |
P478 | volume | 346 |
Q73572591 | A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis |
Q41324843 | A critical review of antibiotic prophylaxis in severe acute pancreatitis |
Q43487976 | A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. |
Q35355748 | A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis |
Q37799431 | Acute Pancreatitis with an Emphasis on Infection |
Q80049381 | Acute necrotizing pancreatitis complicating uteroplacental apoplexy |
Q50185728 | Acute necrotizing pancreatitis: treatment strategy according to the status of infection |
Q55967029 | Acute pancreatitis |
Q43088026 | Acute pancreatitis at the beginning of the 21st century: the state of the art. |
Q41313163 | Acute pancreatitis: nonsurgical management |
Q37878986 | Acute pancreatitis: should we use antibiotics? |
Q43087575 | Acute pancreatitis: the substantial human and financial costs |
Q27014123 | Alcoholic pancreatitis: A tale of spirits and bacteria |
Q81599176 | Antibiotic prophylaxis for severe acute pancreatitis |
Q36419783 | Antibiotic prophylaxis of pancreatic infection in patients with necrotizing pancreatitis: rationale, evidence, and recommendations |
Q24235383 | Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis |
Q24244225 | Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis |
Q24247722 | Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis |
Q41683164 | Antibiotics for the acute abdomen |
Q80212031 | As good as it gets: the study of prophylactic antibiotics in severe acute pancreatitis |
Q92588771 | Assessment of prophylactic antibiotics administration for acute pancreatitis: a meta-analysis of randomized controlled trials |
Q41725823 | Choledocholithiasis and gallstone pancreatitis. |
Q26752372 | Clinical practice guideline: management of acute pancreatitis |
Q80657903 | Commentary |
Q73246584 | Complicated Acute Pancreatitis |
Q78790484 | Conservative management of infected necrosis complicating severe acute pancreatitis |
Q33749866 | Continuous regional arterial infusion for acute pancreatitis: a propensity score analysis using a nationwide administrative database. |
Q36042382 | Contrast-enhanced computed tomography in acute pancreatitis: does contrast medium worsen its course due to impaired microcirculation? |
Q34481905 | Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. |
Q36062888 | Current management of acute pancreatitis |
Q36488210 | Current pharmacotherapeutic recommendations for acute pancreatitis. |
Q35597705 | Detection and identification of bacterial DNA in serum from patients with acute pancreatitis |
Q74263215 | Determinants of ICU mortality in necrotizing pancreatitis: the influence of Staphylococcus epidermidis |
Q33715609 | Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. |
Q50155514 | Difference in microbes contaminating pancreatic necrosis in biliary and alcoholic pancreatitis |
Q34341204 | Disease of the gallbladder and pancreas in pregnancy. |
Q28345121 | Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis |
Q43715574 | Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin |
Q24681368 | Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study |
Q52865134 | Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. |
Q43908089 | Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate |
Q73906897 | Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study |
Q43594364 | Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis--a single-center randomized study |
Q80020629 | Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats |
Q37353872 | Effects of Chai-Qin-Cheng-Qi Decoction on cefotaxime in rats with acute necrotizing pancreatitis |
Q36253169 | Efficacy of antibiotic penetration into pancreatic necrosis |
Q35616683 | Emergency complications of acute and chronic pancreatitis |
Q64066565 | Evaluation and management of acute pancreatitis |
Q33232362 | Evidence-based treatment of acute pancreatitis: a look at established paradigms |
Q51673442 | Factors Predicting Mortality in Severe Acute Pancreatitis |
Q37216673 | Failure to follow evidence-based best practice guidelines in the treatment of severe acute pancreatitis |
Q39475094 | Fluconazole penetration into the pancreas |
Q53946150 | Fulminant acute pancreatitis and infected necrosis: results of open management of the abdomen and "planned" reoperations. |
Q50175506 | Gallstone Pancreatitis |
Q49281477 | Identification and Characterization of Blood and Neutrophil-Associated Microbiomes in Patients with Severe Acute Pancreatitis Using Next-Generation Sequencing |
Q88128100 | Impact of continuous regional arterial infusion in the treatment of acute necrotizing pancreatitis: analysis of a national administrative database |
Q35841266 | Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy |
Q35831948 | Infectious complications of pancreatitis: diagnosis and management |
Q63681577 | Infectious complications, prognostic factors and assessment of anti-infectious management of 212 consecutive patients with acute pancreatitis |
Q33618014 | Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis |
Q41196827 | Interleukin-6: An Early Predictive Marker for Severity of Acute Pancreatitis |
Q52860651 | Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. |
Q78162568 | Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications |
Q37426008 | JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis |
Q64084125 | Management of infected pancreatic necrosis in the setting of concomitant rectal cancer: A case report and review of literature |
Q34512097 | Management of necrotizing pancreatitis |
Q74355008 | Management of necrotizing pancreatitis by repeated operative necrosectomy using a zipper technique |
Q73897664 | Medical and Endoscopic Treatment of Acute Pancreatitis |
Q33724450 | Nonsurgical management of acute pancreatitis. Use of antibiotics |
Q38184562 | Nutrition, inflammation, and acute pancreatitis |
Q34385387 | Optimising outcomes in acute pancreatitis |
Q87345186 | PGC-1α expression is increased in leukocytes in experimental acute pancreatitis |
Q34515744 | Pancreatic polypeptide in pancreatitis |
Q35119700 | Pancreatitis. |
Q74523486 | Penetration of antibiotics into the pancreas in rats: an effect of acute necrotizing pancreatitis |
Q37169329 | Pharmacological approach to acute pancreatitis |
Q38692250 | Pharmacological interventions for acute pancreatitis. |
Q36949427 | Piperacillin-tazobactam penetration into human pancreatic juice. |
Q48002040 | Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis |
Q53521007 | Plasma calprotectin levels in patients suffering from acute pancreatitis. |
Q27003317 | Present and future of prophylactic antibiotics for severe acute pancreatitis |
Q24795769 | Pro/con clinical debate: antibiotics are important in the management of patients with pancreatitis with evidence of pancreatic necrosis |
Q36588446 | Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics |
Q24791550 | Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949] |
Q37106110 | Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis |
Q53946631 | Prophylactic antibiotics alter the bacteriology of infected necrosis in severe acute pancreatitis. |
Q34199880 | Prophylactic antibiotics and pancreatic necrosis |
Q33637252 | Prophylactic antibiotics for severe acute pancreatitis: the beginning of an era. |
Q44630560 | Prophylaxis with Meropenem of Septic Complications in Acute Pancreatitis: A Randomized, Controlled Trial Versus Imipenem |
Q36527025 | Questions about the use of antibiotics in acute pancreatitis |
Q44178742 | Reduction in mortality with delayed surgical therapy of severe pancreatitis |
Q38327176 | Role of antibiotic prophylaxis in necrotizing pancreatitis: a meta-analysis |
Q78157976 | Role of antibiotics in acute pancreatitis: A meta-analysis |
Q33617636 | Role of cytokines and their inhibitors in acute pancreatitis |
Q35358768 | Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis |
Q45221531 | Staphylococcus epidermidis and acute necrotising pancreatitis |
Q43248605 | Surgery for pancreatic necrosis: "whom, when and what". |
Q33741514 | Surgical approach in patients with acute pancreatitis. Is infected or sterile necrosis an indication--in whom should this be done, when, and why? |
Q33724460 | Surgical management of necrotizing pancreatitis |
Q40906799 | Surgical treatment of infected necrosis |
Q37808463 | Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis |
Q38637770 | The Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report from the NASPGHAN Pancreas Committee. |
Q88417552 | The microbiology of infected pancreatic necrosis in the era of minimally invasive therapy |
Q41126594 | The pancreatitis-associated protein I promoter allows targeting to the pancreas of a foreign gene, whose expression is up-regulated during pancreatic inflammation. |
Q33741509 | The role of antibiotic prophylaxis in the treatment of acute pancreatitis |
Q56780678 | The role of antibiotics in the management of patients with acute necrotizing pancreatitis |
Q33686178 | The role of infection in acute pancreatitis |
Q42571548 | The role of the intestine in the pathophysiology and management of severe acute pancreatitis |
Q50155670 | The use of antibiotics for acute pancreatitis: is there a role? |
Q44689739 | Treatment strategy of acute pancreatitis: parenteral nutrition and preventive antibiotic therapy |
Q42576527 | Trends in fungal colonization of pancreatic necrosis in patients undergoing necrosectomy for acute pancreatitis |
Q24685861 | UK guidelines for the management of acute pancreatitis |
Q42265681 | What is New in Acute Pancreatitis? |
Q74491678 | [1997 gastroenterology update--II] |
Q73925427 | [Acute pancreatitis] |
Q80703574 | [Antibiotics and severe acute pancreatitis in Intensive Medicine. Current status. Recommendations of the 7th Consensus Conference of the SEMICYUC] |
Q84364455 | [Diagnosis and treatment of acute pancreatitis. Current recommendations] |
Search more.